Cilo Cybin Holdings Limited (JSE: CCC)
Health Care · Pharmaceuticals · ZA
R1.45
-2.68% today · -73.6% 1Y
Cilo Cybin Holdings Limited (JSE: CCC) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $25.26M and employs 5 people.
Over the last twelve months the share price has lost 73.6%, trading between 0.70 and 6.65.
Tweenvest scores Cilo Cybin Holdings Limited across four factors: quality 61/100, value 47/100. Its strongest factor is quality.
CCC price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $25.26M
- Revenue (TTM)
- $412.87K
- P/E
- —
- EPS
- -3.34
- Dividend yield
- —
- Beta (5Y)
- 0.64
- 52-week high
- R6.65
- 52-week low
- R0.70
- Avg volume (3M)
- —
- Shares outstanding
- 288.09M
- Employees
- 5
- Next earnings
- —
About Cilo Cybin Holdings Limited
Cilo Cybin Holdings Limited is an international enterprise focused on the cultivation, production, and distribution of medicinal cannabis products. Its extensive catalog includes bottled THC and CBD oils, cannabis flowers, and vaping solutions. The company further supplies tinctures, edibles, topical applications, capsules, and specialized devices. Additionally, they manufacture a variety of advanced cannabis extracts, such as full and broad-spectrum refined crude oil, CBD and THC distillates, and pure isolates of CBD, CBG, CBN, and THC. Beyond its product offerings, Cilo Cybin provides essential support services to the cannabis industry, encompassing packaging, storage, and export facilitation. Consumers can directly acquire these goods through its dedicated online retail channel, known as the Brand Shop. Founded in 2018, the firm maintains its base of operations in Centurion, South Africa.
- ISIN
- ZAE000310397
- Founded
- 2018
- Listed since
- Jun 27, 2024
- Exchange
- The Johannesburg Securities Exchange
- Currency
- ZAR
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Korean Drug Co., Ltd.KOSDAQ: A014570 | $25.89M | ₩3,190.00 | -2.60% |
| Neimeth International Pharmaceuticals PlcNGSE: NEIMETH | $25.71M | ₦7.00 | -6.04% |
| MariMed Inc.OTCPK: MRMD | $25.53M | $0.06 | -8.19% |
| IRLAB Therapeutics AB (publ)OM: IRLAB A | $25.37M | Skr1.71 | -8.08% |
| MedRx Co., LtdTSE: 4586 | $25.10M | ¥58.00 | -1.69% |
| Yung Zip Chemical Ind. Co., Ltd.TPEX: 4102 | $24.91M | NT$18.80 | +1.90% |
| iAnthus Capital Holdings, Inc.CNSX: IAN | $24.44M | CA$0.01 | -50.00% |
| Orexo AB (publ)OM: ORX | $24.32M | Skr6.19 | -5.93% |
Figures last refreshed Oct 11, 2026.